Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koen Raemdonck

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 18, 2017
Repurposing cationic amphiphilic drugs as adjuvants to induce lysosomal siRNA escape in nanogel transfected cellsFreya Joris, Lynn De Backer, Thijs Van de Vyver, et al.
Current Pharmaceutical Design|June 23, 2012
TNF-α/cycloheximide-induced oxidative stress and apoptosis in murine intestinal epithelial MODE-K cellsDinesh Babu, Stefaan J Soenen, Koen Raemdonck, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 21, 2015
Bio-inspired pulmonary surfactant-modified nanogels: A promising siRNA delivery systemLynn De Backer, Kevin Braeckmans, Marc C A Stuart, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 16, 2014
Probing the size limit for nanomedicine penetration into Burkholderia multivorans and Pseudomonas aeruginosa biofilmsKatrien Forier, Anne-Sophie Messiaen, Koen Raemdonck, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 17, 2024
Evaluating β<sub>2</sub>-agonists as siRNA delivery adjuvants for pulmonary surfactant-coated nanogel inhalation therapyPieterjan Merckx, Griet Conickx, Evy Blomme, et al.
Nanomedicine (London, England)|June 13, 2013
Unraveling the effects of siRNA carrier systems on cell physiology: a multiparametric approach demonstrated on dextran nanogelsStefaan J Soenen, Lynn De Backer, Bella Manshian, et al.
Advanced Drug Delivery Reviews|July 29, 2021
Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message acrossAn-Katrien Minnaert, Helena Vanluchene, Rein Verbeke, et al.
Pharmaceutics|August 28, 2019
Nanocarrier Lipid Composition Modulates the Impact of Pulmonary Surfactant Protein B (SP-B) on Cellular Delivery of siRNARoberta Guagliardo, Pieterjan Merckx, Agata Zamborlin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 10, 2023
The alpha-adrenergic antagonist prazosin promotes cytosolic siRNA delivery from lysosomal compartmentsThijs Van de Vyver, Cristina Muntean, Iuliia Efimova, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 27, 2015
Hybrid pulmonary surfactant-coated nanogels mediate efficient in vivo delivery of siRNA to murine alveolar macrophagesLynn De Backer, Thomas Naessens, Stefaan De Koker, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 18, 2017
Repurposing cationic amphiphilic drugs as adjuvants to induce lysosomal siRNA escape in nanogel transfected cellsFreya Joris, Lynn De Backer, Thijs Van de Vyver, et al.
Current Pharmaceutical Design|June 23, 2012
TNF-α/cycloheximide-induced oxidative stress and apoptosis in murine intestinal epithelial MODE-K cellsDinesh Babu, Stefaan J Soenen, Koen Raemdonck, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 21, 2015
Bio-inspired pulmonary surfactant-modified nanogels: A promising siRNA delivery systemLynn De Backer, Kevin Braeckmans, Marc C A Stuart, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 16, 2014
Probing the size limit for nanomedicine penetration into Burkholderia multivorans and Pseudomonas aeruginosa biofilmsKatrien Forier, Anne-Sophie Messiaen, Koen Raemdonck, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 17, 2024
Evaluating β<sub>2</sub>-agonists as siRNA delivery adjuvants for pulmonary surfactant-coated nanogel inhalation therapyPieterjan Merckx, Griet Conickx, Evy Blomme, et al.
Nanomedicine (London, England)|June 13, 2013
Unraveling the effects of siRNA carrier systems on cell physiology: a multiparametric approach demonstrated on dextran nanogelsStefaan J Soenen, Lynn De Backer, Bella Manshian, et al.
Advanced Drug Delivery Reviews|July 29, 2021
Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message acrossAn-Katrien Minnaert, Helena Vanluchene, Rein Verbeke, et al.
Pharmaceutics|August 28, 2019
Nanocarrier Lipid Composition Modulates the Impact of Pulmonary Surfactant Protein B (SP-B) on Cellular Delivery of siRNARoberta Guagliardo, Pieterjan Merckx, Agata Zamborlin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 10, 2023
The alpha-adrenergic antagonist prazosin promotes cytosolic siRNA delivery from lysosomal compartmentsThijs Van de Vyver, Cristina Muntean, Iuliia Efimova, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 27, 2015
Hybrid pulmonary surfactant-coated nanogels mediate efficient in vivo delivery of siRNA to murine alveolar macrophagesLynn De Backer, Thomas Naessens, Stefaan De Koker, et al.
Pageof 9